CareTrust REIT (CTRE)
(Delayed Data from NYSE)
$29.21 USD
+0.33 (1.14%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $29.21 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for CareTrust REIT, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 218 | 196 | 192 | 178 | 163 |
Cost Of Goods | 6 | 4 | 4 | 3 | 3 |
Gross Profit | 212 | 192 | 189 | 176 | 160 |
Selling & Adminstrative & Depr. & Amort Expenses | 76 | 76 | 93 | 71 | 70 |
Income After Depreciation & Amortization | 135 | 116 | 96 | 105 | 90 |
Non-Operating Income | -41 | -94 | 0 | 0 | -16 |
Interest Expense | 41 | 30 | 24 | 24 | 28 |
Pretax Income | 54 | -8 | 72 | 81 | 46 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 54 | -8 | 72 | 81 | 46 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 54 | -8 | 72 | 81 | 46 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 194 | 175 | 164 | 163 | 148 |
Depreciation & Amortization (Cash Flow) | 58 | 58 | 68 | 59 | 58 |
Income After Depreciation & Amortization | 135 | 116 | 96 | 105 | 90 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 106.15 | 96.70 | 96.09 | 95.21 | 93.10 |
Diluted EPS Before Non-Recurring Items | 0.50 | -0.08 | 0.74 | 0.85 | 0.49 |
Diluted Net EPS (GAAP) | 0.50 | -0.08 | 0.74 | 0.85 | 0.49 |
Fiscal Year end for CareTrust REIT, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 68.89 | 63.07 | 59.73 | 55.88 | 51.55 |
Cost Of Goods | 1.98 | 1.80 | 1.73 | 2.17 | 1.39 |
Gross Profit | 66.92 | 61.27 | 58.00 | 53.71 | 50.16 |
SG&A, R&D, and Dept/Amort Expenses | 20.25 | 20.95 | 21.24 | 19.79 | 18.10 |
Income After SG&A, R&D, and Dept/Amort Expenses | 46.67 | 40.32 | 36.76 | 33.92 | 32.06 |
Non-Operating Income | -27.57 | -3.35 | -2.72 | -13.48 | -21.52 |
Interest Expense | 8.68 | 8.23 | 8.27 | 11.75 | 11.04 |
Pretax Income | 10.42 | 28.75 | 26.29 | 8.69 | -0.48 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | -0.34 | 0.00 | 0.00 | -0.01 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 10.42 | 28.75 | 26.29 | 8.69 | -0.48 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 10.76 | 28.75 | 26.30 | 8.70 | -0.48 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 145.26 | 133.20 | 121.68 | 104.31 | 99.12 |
Diluted EPS Before Non-Recurring Items | 0.07 | 0.22 | 0.22 | 0.08 | 0.00 |
Diluted Net EPS (GAAP) | 0.07 | 0.22 | 0.24 | 0.08 | -0.01 |